May 08, 2018
2 min read
Save

Blacks with lupus have higher comorbidity burden than whites

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

April Barnado

Black patients with systemic lupus erythematosus demonstrated an increased comorbidity burden in every organ system compared with both whites with lupus and healthy blacks, according to findings published in Arthritis Research & Therapy.

“Our study is important because it uses a novel electronic health record (EHR)-based technique called phenome-wide association study (PheWAS) to examine racial disparities in systemic lupus erythematosus (SLE),” April Barnado, MD, MSCI, of Vanderbilt University Medical Center, told Healio Rheumatology. “PheWAS scan across billing codes in the electronic health record (EHR) similar to a GWAS scans across the genome. PheWAS have uncovered novel genetic associations in autoimmune diseases and been validated in follow-up studies.”

To determine the differences in comorbidities among black and white patients with SLE, the researchers drew data from a de-identified version of the electronic health records (EHR) at Vanderbilt University Medical Center, which includes 2.8 million individuals and corresponding longitudinal information collected during the past 7 decades. The researchers identified 270 blacks and 715 whites with SLE, as well as 1,424 matched black control patients who did not have the disease.

Black patients with systemic lupus erythematosus demonstrated an increased comorbidity burden in every organ system compared with both whites with lupus and healthy blacks.
Source: Shutterstock

Data in the de-identified EHR included diagnostic and procedure codes, demographics, inpatient and outpatient notes, laboratory values, radiology and pathology results, and medication orders. The researchers performed phenome-wide association studies to compare cases among the three groups of patients, controlling for age, sex and race. In addition, the researchers used a false discovery rate (FDR) P value of .05 for multiple testing.

According to Barnado and colleagues, black patients with SLE had more comorbidities in every organ system compared with white patients with SLE, with the most prominent examples being hypertension (OR = 4.25; FDR P = 5.49 × 1015), renal dialysis (OR = 10.9; FDR P = 8.75 × 1014) and pneumonia (OR = 3.57; FDR P = 2.32 × 108). Black patients with SLE were also more likely to have comorbidities in every organ system when compared with blacks in the control group. The most significant comorbidities included renal failure (OR = 9.55; FDR P = 2.26 × 1040) and hypertensive heart and renal disease (OR = 8.08; FDR P = 1.78 × 1022).

After adjusting for race, age and sex, and including patients in all three groups, SLE was independently associated with renal, cardiovascular and infectious diseases (P < .01).

“These findings have important clinical implications that African Americans with SLE have a high burden of comorbid diseases and need not only timely rheumatologic care but also primary and specialist care,” Barnado said. “Our findings build upon cohort and administrative studies by focusing on African American SLE subjects and capturing both inpatient and outpatient diagnoses over decades of follow-up. PheWAS provide a robust approach to scan the entire EHR and systematically evaluate longitudinal data.” – by Jason Laday

Disclosure: Barnado reports no relevant financial disclosures. Please see the study for all other authors’ relevant financial disclosures.